New asthma pill tested for Hard-to-Control breathing

NCT ID NCT03226392

Completed Disease control Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This study tested whether adding an investigational pill called QAW039 to standard asthma treatments could improve lung function and symptoms in people whose asthma was not well-controlled. Over 700 adults and teens took either the new pill or a placebo (dummy pill) for 12 weeks while continuing their usual asthma medicines. Researchers measured changes in breathing tests, daily symptoms, and quality of life.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Novartis Investigative Site

Andalusia, Alabama, 36420, United States
Novartis Investigative Site

Birmingham, Alabama, 35209, United States
Novartis Investigative Site

Tucson, Arizona, 85745, United States
Novartis Investigative Site

Los Angeles, California, 90048, United States
Novartis Investigative Site

Newport Beach, California, 92663, United States
Novartis Investigative Site

Rolling Hills Estates, California, 90274, United States
Novartis Investigative Site

San Diego, California, 92117, United States
Novartis Investigative Site

San Diego, California, 92120, United States
Novartis Investigative Site

San Jose, California, 95117, United States
Novartis Investigative Site

Stockton, California, 95207, United States
Novartis Investigative Site

Colorado Springs, Colorado, 80907, United States
Novartis Investigative Site

Denver, Colorado, 80230, United States
Novartis Investigative Site

Lafayette, Colorado, 80026, United States
Novartis Investigative Site

Miami, Florida, 33176, United States
Novartis Investigative Site

Miami Gardens, Florida, 33169, United States
Novartis Investigative Site

Tallahassee, Florida, 32308, United States
Novartis Investigative Site

Winter Park, Florida, 32789, United States
Novartis Investigative Site

Paducah, Kentucky, 42001, United States
Novartis Investigative Site

Columbia, Maryland, 21044, United States
Novartis Investigative Site

White Marsh, Maryland, 21162, United States
Novartis Investigative Site

North Dartmouth, Massachusetts, 02747-3322, United States
Novartis Investigative Site

Ann Arbor, Michigan, 48106, United States
Novartis Investigative Site

Minneapolis, Minnesota, 55402, United States
Novartis Investigative Site

Rochester, Minnesota, 55905, United States
Novartis Investigative Site

Saint Charles, Missouri, 63301, United States
Novartis Investigative Site

St Louis, Missouri, 63110, United States
Novartis Investigative Site

St Louis, Missouri, 63141, United States
Novartis Investigative Site

Warrensburg, Missouri, 64093, United States
Novartis Investigative Site

Omaha, Nebraska, 68134, United States
Novartis Investigative Site

Brooklyn, New York, 11235, United States
Novartis Investigative Site

Raleigh, North Carolina, 27607, United States
Novartis Investigative Site

Cincinnati, Ohio, 45245, United States
Novartis Investigative Site

Columbus, Ohio, 43215, United States
Novartis Investigative Site

Marion, Ohio, 43302, United States
Novartis Investigative Site

Mayfield Heights, Ohio, 44124, United States
Novartis Investigative Site

Tulsa, Oklahoma, 74136, United States
Novartis Investigative Site

Altoona, Pennsylvania, 16602, United States
Novartis Investigative Site

Pittsburgh, Pennsylvania, 15241, United States
Novartis Investigative Site

Mt. Pleasant, South Carolina, 29464, United States
Novartis Investigative Site

Dallas, Texas, 75231, United States
Novartis Investigative Site

New Braunfels, Texas, 78130, United States
Novartis Investigative Site

San Antonio, Texas, 78205, United States
Novartis Investigative Site

Murray, Utah, 84107, United States
Novartis Investigative Site

Newport News, Virginia, 23606, United States
Novartis Investigative Site

Spokane, Washington, 99204, United States
Novartis Investigative Site

Goiânia, Goiás, 74110-030, Brazil
Novartis Investigative Site

Porto Alegre, Porto Alegre RS, 90610 000, Brazil
Novartis Investigative Site

Porto Alegre, Rio Grande do Sul, 90020-090, Brazil
Novartis Investigative Site

Porto Alegre, Rio Grande do Sul, 90610-000, Brazil
Novartis Investigative Site

Blumenau, Santa Catarina, 89030101, Brazil
Novartis Investigative Site

São Bernardo do Campo, São Paulo, 09715 090, Brazil
Novartis Investigative Site

São Paulo, São Paulo, 05437 010, Brazil
Novartis Investigative Site

Sorocaba, São Paulo, Brazil
Novartis Investigative Site

Pleven, 5800, Bulgaria
Novartis Investigative Site

Rousse, 7002, Bulgaria
Novartis Investigative Site

Sofia, 1000, Bulgaria
Novartis Investigative Site

Stara Zagora, 6000, Bulgaria
Novartis Investigative Site

Kingston, Ontario, K7L 2V7, Canada
Novartis Investigative Site

Toronto, Ontario, M6H 3M2, Canada
Novartis Investigative Site

Toronto, Ontario, M9V 4B4, Canada
Novartis Investigative Site

Windsor, Ontario, N8X 5A6, Canada
Novartis Investigative Site

Ibagué, Tolima Department, 730006, Colombia
Novartis Investigative Site

Bogota DC, 110221, Colombia
Novartis Investigative Site

Bogotá, 110111, Colombia
Novartis Investigative Site

Bucaramanga, Colombia
Novartis Investigative Site

Berlin, 10367, Germany
Novartis Investigative Site

Erlangen, 91052, Germany
Novartis Investigative Site

Frankfurt, 60389, Germany
Novartis Investigative Site

Halle, 06108, Germany
Novartis Investigative Site

Hamburg, 20354, Germany
Novartis Investigative Site

Hanover, 30167, Germany
Novartis Investigative Site

Leipzig, 04357, Germany
Novartis Investigative Site

Lübeck, 23552, Germany
Novartis Investigative Site

Hajdúnánás, HUN, 4080, Hungary
Novartis Investigative Site

Kapuvár, HUN, 9330, Hungary
Novartis Investigative Site

Püspökladány, HUN, 4150, Hungary
Novartis Investigative Site

Budapest, 1106, Hungary
Novartis Investigative Site

Pécs, 7635, Hungary
Novartis Investigative Site

Siófok, 8600, Hungary
Novartis Investigative Site

Szigetszentmiklós, H-2310, Hungary
Novartis Investigative Site

Ahmedabad, Gujarat, 380 060, India
Novartis Investigative Site

Vadodara, Gujarat, 390022, India
Novartis Investigative Site

Nashik, Maharashtra, 422007, India
Novartis Investigative Site

Bikaner, Rajasthan, 334 001, India
Novartis Investigative Site

Coimbatore, Tamil Nadu, 641 045, India
Novartis Investigative Site

Dehradun, Uttarakhand, 248001, India
Novartis Investigative Site

Ashkelon, 78278, Israel
Novartis Investigative Site

Haifa, 3436212, Israel
Novartis Investigative Site

Jerusalem, Israel
Novartis Investigative Site

Rehovot, 76100, Israel
Novartis Investigative Site

Brescia, BS, 25123, Italy
Novartis Investigative Site

Florence, FI, 50134, Italy
Novartis Investigative Site

Rozzano, MI, 20089, Italy
Novartis Investigative Site

Pisa, PI, 56124, Italy
Novartis Investigative Site

Milan, 20157, Italy
Novartis Investigative Site

Lima Cercado, Lima region, 01, Peru
Novartis Investigative Site

San Isidro, Lima region, 27, Peru
Novartis Investigative Site

San Martín de Porres, Lima region, 31, Peru
Novartis Investigative Site

Cusco, 84, Peru
Novartis Investigative Site

Lima, 1, Peru
Novartis Investigative Site

Piura, 2000, Peru
Novartis Investigative Site

San Juan, 00909, Puerto Rico
Novartis Investigative Site

Barnaul, 656024, Russia
Novartis Investigative Site

Chelyabinsk, 454021, Russia
Novartis Investigative Site

Moscow, 109544, Russia
Novartis Investigative Site

Moscow, 115478, Russia
Novartis Investigative Site

N.Novgorod, 603126, Russia
Novartis Investigative Site

Penza, 440067, Russia
Novartis Investigative Site

Perm, 614068, Russia
Novartis Investigative Site

Ryazan, 390039, Russia
Novartis Investigative Site

Saint Petersburg, 191186, Russia
Novartis Investigative Site

Saint Petersburg, 194354, Russia
Novartis Investigative Site

Saint Petersburg, 197022, Russia
Novartis Investigative Site

Stavropol, 355000, Russia
Novartis Investigative Site

Yaroslavl, 150054, Russia
Novartis Investigative Site

Yekaterinburg, 620109, Russia
Novartis Investigative Site

Wŏnju, Gangwon-do, 26427, South Korea
Novartis Investigative Site

Bucheon-si, Gyeonggi-do, 14584, South Korea
Novartis Investigative Site

Hwaseong-si, Gyeonggi-do, 18450, South Korea
Novartis Investigative Site

Suwon, Gyeonggi-do, 16499, South Korea
Novartis Investigative Site

Seoul, Korea, 03312, South Korea
Novartis Investigative Site

Seoul, Seocho Gu, 06591, South Korea
Novartis Investigative Site

Daegu, 705703, South Korea
Novartis Investigative Site

Incheon, 21431, South Korea
Novartis Investigative Site

Seoul, 05505, South Korea
Novartis Investigative Site

Marbella, Andalusia, 29603, Spain
Novartis Investigative Site

Málaga, Andalusia, 29010, Spain
Novartis Investigative Site

Laredo, Cantabria, 39770, Spain
Novartis Investigative Site

Pozuelo de Alarcón, Madrid, 28223, Spain
Novartis Investigative Site

Barcelona, Vic, 08500, Spain
Novartis Investigative Site

Barcelona, 08006, Spain
Novartis Investigative Site

Barcelona, 08540, Spain
Novartis Investigative Site

Girona, 17005, Spain
Novartis Investigative Site

Santiago de Compostela, 1506, Spain
Novartis Investigative Site

Zaragoza, 50009, Spain
Novartis Investigative Site

Lund, SE-221 85, Sweden
Novartis Investigative Site

Umeå, 907 40, Sweden
Novartis Investigative Site

Visby, 621 50, Sweden
Novartis Investigative Site

Bab Saadoun, 1007, Tunisia
Novartis Investigative Site

Haiphong, 180000, Vietnam
Novartis Investigative Site

Hanoi, 100000, Vietnam
Novartis Investigative Site

Ho Chi Minh City, 700000, Vietnam

Conditions

Explore the condition pages connected to this study.

ASTHMA